Old Web
English
Sign In
Acemap
>
authorDetail
>
Flora Mazerolle
Flora Mazerolle
Myelodysplastic syndromes
Medicine
Physical therapy
eortc qlq c30
Chronic myelomonocytic leukemia
3
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Measuring patient-reported physical functioning and fatigue in myelodysplastic syndromes using a modular approach based on EORTC QLQ-C30.
2021
Journal of Patient-Reported Outcomes
Antoine Regnault
Farrah Pompilus
Anna Ciesluk
Flora Mazerolle
Rafael Bejar
Robert J. Fram
Douglas V. Faller
Patrick Marquis
Jill A Bell
Show All
Source
Cite
Save
Citations (0)
Randomized Phase 2 Trial of Pevonedistat Plus Azacitidine Versus Azacitidine in Higher-Risk Myelodysplastic Syndromes/Chronic Myelomonocytic Leukemia or Low-Blast Acute Myeloid Leukemia: Exploratory Analysis of Patient-Reported Outcomes
2020
Blood
Joshua F. Zeidner
Flora Mazerolle
Jill A Bell
Lauren E. Cain
Douglas V. Faller
Mehul Dalal
Antoine Regnault
Robert J. Fram
Show All
Source
Cite
Save
Citations (0)
Assessing Patient-Reported Outcomes in People with Myelodysplastic Syndromes: Can a Customized Selection of Items from the EORTC Library Enhance the EORTC QLQ-C30?
2018
Blood
Jill A Bell
Farrah Pompilus
Anna Christian
Flora Mazerolle
Fatima Scipione
Rafael Bejar
Aaron Galaznik
Robert J. Fram
Douglas V. Faller
Stefan J. Cano
Antoine Regnault
Show All
Source
Cite
Save
Citations (0)
1